The Pharmacovigilance Risk
Assessment Committee (PRAC)
has started a review of nasal
and mouth sprays containing the
antibiotic fusafungine, used to treat
infections of the upper airways.
The review will encompass
the benefits and risks of these
medicines and issue an opinion
on their marketing authorisations
across the European Union, the
European Medicines Agency said.
For highlights from the PRAC 07-
10 Sep meeting and more on the
fusafungine review,The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 15
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.